Ovarian Cancer
The Ovarian Cancer Center at Roswell Park Cancer Institute
The Gynecologic Center at Roswell Park is staffed by a team of specialists with expertise in the care and treatment of all cancers of the reproductive system from diagnosis through follow-up.
All members of the Department of Gynecology at Roswell Park have specialized training in gynecologic cancers.
Ovarian cancer patient Sharon Meckes said she finds comfort in knowing that Roswell is one of a group of facilities that collaborate to bring forth the latest advances for patients.
As the technology and treatments across the nation and the world are developed, we can educate ourselves and participate in trials and treatment plans that may turn our situation around and improve our life.
A research collaboration by Roswell Park gynecological oncologist Kunle Odunsi, MD, PhD, and Thomas Szyperski, PhD, of the University at Buffalo’s Department of Chemistry is showing great potential to lead to an early screening test capable of detecting ovarian cancer when it is most curable.
Researchers at RPCI are working to develop a promising vaccine to unleash the power of the immune system against ovarian cancer. Kunle Odunsi, MD, PhD, Department of Gynecologic Oncology, and colleagues are combining efforts to evaluate the safety and effectiveness of a vaccine treatment which they hope will be tested in large-scale clinical studies.
The Gilda Radner Familial Ovarian Registry is pursuing research into causes of familial cancer in collaboration with investigators at Roswell Park Cancer Institute, Stanford University School of Medicine and Cambridge University. Our goals are to identify new genes associated with familial ovarian cancer, thereby improving genetic and psychosocial counseling for individuals and families and to characterize lifestyle choices (i.e., oral contraceptive use, hormone replacement therapy, number of pregnancies) that reduce ovarian cancer risk in women who may be more susceptible to the disease. We hope to acquire information that will lead to better methods for detecting ovarian cancer, for reliable predictive testing for cancer predisposition and ultimately, preventing the disease in future generations.
